Orthox Closes $12.5M Series A Financing For Clinical Trials Of Knee Cartilage Repair Fibrofix™ Product Platform
Feb 09, 2022•over 3 years ago
Amount Raised
$12.5 Million
Round Type
series a
Description
Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.3m (£3.2m) to close its $12.5m (£9.2m) Series A financing round. The financing will support further clinical trials of its lead product, FibroFixTM, at Southmead Hospital Bristol, UK and in Budapest, Hungary.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech